# Nordic Nanovector to acquire Thor Medical

Nordic Nanovector ASA and Thor Medical AS entered into a definitive share exchange agreement for an all-share transaction. The combined company will focus on radionuclide production for cancer treatment, with Scatec Innovation becoming the largest shareholder.

- Type: Acquisition
- Announced: 2023-06-22
- Where: Norway
- Status: announced
- Products: alpha-emitting radionuclides for cancer treatment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Nordic Nanovector ASA](https://endata.com/companies/70996.md) (acquirer)
- [Thor Medical AS](https://endata.com/companies/70997.md) (target)
- [Scatec Innovation AS](https://endata.com/companies/70998.md) (investor)

## Sources

- [thormedical.com](https://www.thormedical.com/artikler/nordic-nanovector-to-acquire-thor-medical), 2023-06-22: "The acquisition of Thor Medical is an important strategic step for Nordic Nanovector"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
